CenturyLink, Inc. (CTL) PT Lowered to $29 at UBS; 'Trends to Weaken in 2Q...Lowering 2Q & 2017 Estimates'

UBS lowered its price target on CenturyLink, Inc. (NYSE: CTL) to $29.00 (from $31.00) while maintaining a Buy rating, following an update of second quarter and 2017 estimates.

Analyst Batya Levi notes expectations for second quarter results to achieve the low-end of guidance fueled by incremental pressure on revenues and limited cost cutting, while recent lawsuits have weight shares, reflecting lower second quarter and 2017 estimates.

You May Also Be Interested In

• Amazon.com (AMZN) PT Raised to $215 at UBS
• Bristol-Myers Squibb Co. (BMY) PT Lowered to $64 at Truist Securities
• Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) PT Raised to JPY18,800 at Nomura/Instinet